Application of Artificial Intelligence in the Pharmaceutical Industry
Abstract
Background: The potentials of artificial intelligence (AI) have permeated all industries and fields, and the advantages of AI are extensively employed. This technology offers a wide range of benefits in the pharmaceutical industry, including reducing human interventions and increasing the speed and accuracy of tasks. This can expedite time-consuming activities, such as drug discovery, production, clinical trials,
research and development, and ultimately, determining a drug’s position in target markets.
Methods: A comprehensive scope review was performed in this descriptive, applied study on the applications of AI in the pharmaceutical industry in Iran. Relevant data were meticulously gathered and extracted from diverse sources, including various search engines, key databases, such as Medline, PubMed, Elsevier, and the Iranian Center for Scientific Information and Documentation, and information databases, reference books, and reports from the World Health Organization. These results represent our research on key themes, including AI, the pharmaceutical industry, drug production, innovation, and evolution. Our main focus lies on the application of AI in the manufacturing part of the pharmaceutical industry, with a deliberate decision not to delve into the technical aspects. This approach allowed us to prioritize a comprehensive understanding of the practical implications and advancements in the manufacturing processes facilitated by artificial intelligence.
Results: The retrieved studies showed that AI has the potential to enhance crucial processes in pharmaceutical companies across various dimensions. These potential capabilities are observed in areas such as quality control, human resource management, research and development, finance, supply chain management, logistics, data management, operations management, customer relationship management, and commerce, which are further discussed.
Conclusions: Pharmaceutical companies can utilize the tools provided by AI in various value-creating processes to enhance their efficiency and effectiveness. This requires the adoption and integration of this innovative technology at various levels of organizational planning so that these companies can harness the greater potential it offers with appropriate investments.
[2] H. Malik, S. Srivastava, Y. R. Sood and A. Ahmad, Applications of Artificial intelligence techniques in engineering, Springer, 2018.
[3] A. Sahu, J. Mishra and N. Kushwaha, "Artificial Intelligence (AI) in Drugs and Pharmaceuticals.," Combinatorial chemistry & high throughput screening, vol. 25, no. 11, pp. 1818-1837, 2022.
[4] J. Rantanen and J. Khinast, "The Future of Pharmaceutical Manufacturing Sciences.," Journal of pharmaceutical sciences, pp. 3612-3638, 2015.
[5] S. Bennett, J. D. Quick and G. Valasquez, "WHO Action Programme on Essential Drugs. Public-private roles in the pharmaceutical sector : implications for equitable access and rational drug use. World Health Organization.," 1997. [Online]. Available: https://apps.who.int/iris/handle/10665/63693.
[6] N. Yousefi, G. Mehralian, F. Peiravian and F. Noee, "Generic substitution policy implementation: A pharmacists' perspective survey," Journal of Generic Medicines, vol. 12, no. 1, pp. 17-25, 2015.
[7] "AI in Pharmaceutical Market Size, Share, Report 2021-2030 [Internet].," 2022. [Online]. Available: https://www.precedenceresearch.com/ai-in-pharmaceutical-market.
[8] N. S. Arden, A. C. Fisher , K. Tyner, L. X. Yu, S. L. Lee and M. Kopcha, "Industry 4.0 for pharmaceutical manufacturing: Preparing for the smart factories of the future.," International journal of pharmaceutics, p. 120554, 2021.
[9] D. Paul, G. Sanap, S. Shenoy, D. Kalyane, K. Kalia and R. K. Tekade, "Artificial intelligence in drug discovery and development.," Drug discovery today, pp. 80-93, 2021.
[10] J. A. Miller, M. E. Fredrickson, J. M. Greene, M. Jay and M. O. Oyewumi, "Reimagining drug manufacturing paradigm in today's pharmacy landscape.," Journal of the American Pharmacists Association : JAPhA, pp. 1761-1764, 2022.
[11] C. Sarkar, B. Das, V. S. Rawat, J. B. Wahlang, A. Nongpiur, I. Tiewsoh, N. M. Lyngdoh, D. Das, M. Bidarolli and H. T. Sony, "Artificial Intelligence and Machine Learning Technology Driven Modern Drug Discovery and Development," International Journal of Molecular Sciences, 2023.
[12] J. S. Srai, C. Badman, M. Krumme, M. Futran and C. Johnston, "Future supply chains enabled by continuous processing--opportunities and challenges. May 20-21, 2014 Continuous Manufacturing Symposium.," Journal of pharmaceutical sciences, pp. 840-849, 2015.
[13] S. Kot, H. Iqbal-Hussain, S. Bilan, M. Haseeb and L. Mihardjo, "The role of artificial intelligence recruitment and quality to explain the phenomenon of employer reputation," Journal of Business Economics and Management, pp. 867-883, 2021.
[14] I. Kulkov, "The role of artificial intelligence in business transformation: A case of pharmaceutical companies," Technology in Society, p. 101629, 2021.
[15] Á. Machancoses, Ó. F. Martínez and J. Luis, "Using artificial intelligence methods to speed up drug discovery," Expert opinion on drug discovery, vol. 14, no. 8, pp. 769-777, 2019.
[16] N. Fleming, "How artificial intelligence is changing drug discovery," Nature, vol. 557, no. 7707, pp. S55-S57, 2018.
[17] S. Abramavičius, A. Stundžienė, L. Korsakova, M. Venslauskas and E. Stankevičius, "Stock price reaction to the drug development setbacks in the pharmaceutical industry.," Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences, pp. 1-11, 2021.
[18] S. Reddy, S. Allan, S. Coghlan and P. Cooper, "A governance model for the application of AI in health care.," Journal of the American Medical Informatics Association : JAMIA, pp. 491-497, 2020.
[19] L. A. Finelli and V. Narasimhan, "Leading a Digital Transformation in the Pharmaceutical Industry: Reimagining the Way We Work in Global Drug Development.," Clinical pharmacology and therapeutics, pp. 756-761, 2020.
[20] H. Patel, "A Review: Future Aspects of Artificial Intelligence Big Data And Robotics In Pharmaceutical Industry," 2021.
[21] R. Gupta, D. Srivastava, M. Sahu, S. Tiwari, R. K. Ambasta and P. Kumar, "Artificial intelligence to deep learning: machine intelligence approach for drug discovery.," Molecular diversity, pp. 1315-1360, 2021.
[22] N. M. Davies, "Adapting artificial intelligence into the evolution of pharmaceutical sciences and publishing: Technological darwinism.," Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques, p. 11349, 2023.
[23] E. López-Rubio, D. A. Elizondo, M. Grootveld, J. M. Jerez and R. M. Luque-Baena, "Computational intelligence techniques in medicine.," Computational and mathematical methods in medicine, p. 196976, 2015.
[24] V. Khanna, R. Ahuja and H. Popli, "Role of artificial intelligence in pharmaceutical marketing: a comprehensive review," Journal of Advanced Scientific Research, pp. 54-61, 2020.
[25] A. Flynn, "Using artificial intelligence in health-system pharmacy practice: Finding new patterns that matter," American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, vol. 76, no. 9, pp. 622-627, 2019.
[26] K. P. Donepudi, "AI and Machine Learning in Retail Pharmacy: Systematic Review of Related Literature," ABC Journal of Advanced Research, vol. 7, no. 2, p. 109–112, 2018.
[27] D. V. Mishra, "Artificial Intelligence: The Beginning of a New Era in Pharmacy Profession," Asian Journal of Pharmaceutics (AJP), vol. 12, no. 02, 2018.
[28] O. Khan, M. Parvez, P. Kumari, S. Parvez and S. Ahmad, "The future of pharmacy: How AI is revolutionizing the industry," Intelligent Pharmacy, vol. 1, no. 32-40, p. 1, 2023.
[29] M. El Khatib and G. Ahmed, "Robotic pharmacies potential and limitations of artificial intelligence: a case study," International Journal of Business Innovation and Research, vol. 23, p. 298, 2020.
[30] A. P. Del Castillo, "A law on robotics and artificial intelligence in the EU?," ETUI, The European Trade Union Institute, 2020.
[31] C. Siegmann and M. Anderljung, "The Brussels Effect and Artificial Intelligence: How EU regulation will impact the global AI market," 2022.
[32] M. A. Raza, S. Aziz, M. Noreen, A. Saeed, I. Anjum, M. Ahmed and S. Raza, "Artificial Intelligence (AI) in Pharmacy: An Overview of Innovations," INNOVATIONS in pharmacy, vol. 13, p. 13, 2022.
[33] K.-K. Mak and M. R. Pichika, "Artificial intelligence in drug development: present status and future prospects.," Drug discovery today, vol. 34, no. 3, pp. 773-780, 2019.
| Files | ||
| Issue | Vol 7, No 4 (2023) | |
| Section | Review Article | |
| DOI | https://doi.org/10.18502/htaa.v7i4.14656 | |
| Keywords | ||
| Artificial intelligence Pharmaceutical industry Drug production Innovation Evolution | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
